WayneL.HofstetterMD
Thoracic Surgery • Houston, TXCardiovascular Surgery
Professor of Surgery and Deputy Chair, University Tex Houston
Dr. Hofstetter is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161
Education & Training
Texas Heart InstituteFellowship, Thoracic Surgery, 2000 - 2002
University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Surgery, 1993 - 1999
Keck School of Medicine of the University of Southern CaliforniaClass of 1993
Certifications & Licensure
FL State Medical License 2021 - Present
AZ State Medical License 2022 - 2026
CA State Medical License 1995 - 2026
GA State Medical License 2022 - 2026
TN State Medical License 2022 - 2026
LA State Medical License 2022 - 2025
MS State Medical License 2022 - 2025- American Board of Surgery Surgery
- American Board of Thoracic Surgery Thoracic and Cardiac Surgery
- Join now to see all
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- Nutritional Supplementation in Reducing Complications in Patients With Locally Advanced Esophageal Cancer Undergoing Chemotherapy, Radiation Therapy, and/or Surgery Start of enrollment: 2019 Mar 14
- Microwave Ablation or Wedge Resection for the Treatment of Lung, Sarcoma and Colorectal Lesions, ALLUME Study Start of enrollment: 2019 Aug 07
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 358 citationsNeoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial.Tina Cascone, William N. William, Annikka Weissferdt, Cheuk Hong Leung, Heather Lin
Nature Medicine. 2021-02-18 - 85 citationsProton beam therapy and concurrent chemotherapy for esophageal cancer.Steven H. Lin, Ritsuko Komaki, Zhongxing Liao, C. Wei, Bevan Myles
International Journal of Radiation Oncology, Biology, Physics. 2012-07-01 - 22 citationsNuclear expression of Gli-1 is predictive of pathologic complete response to chemoradiation in trimodality treated oesophageal cancer patients.Roopma Wadhwa, Xuemei Wang, Veerabhadran Baladandayuthapani, Bin Liu, Hironori Shiozaki
British Journal of Cancer. 2017-08-22
Journal Articles
- Surgeon Assessment of Gastric Cancer Lymph Node Specimens with a Video of TechniquePaul F Mansfield, Wayne L Hofstetter, Keith F Fournier, Brian D Badgwell, Jaffer A Ajani, John M Skibber, Jeannelyn S Estrella, Journal of gastrointestinal surgery
Press Mentions
A ‘Major Step Forward’ for Patients with Esophageal CancerMarch 31st, 2021- 10 Things to Know About Esophageal CancerNovember 10th, 2020
Taking Charge of Esophageal Cancer TreatmentJanuary 3rd, 2017- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
